acamprosate has been researched along with Depression, Endogenous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gofman, AG; Ponizovskiy, PA | 1 |
Bell, JR; Haber, PS; Morley, KC; Phung, N; Reid, SC; Richardson, K; Sannibale, C; Teesson, M; Thomson, C; Weltman, M | 1 |
Allen, J; Fertig, J; Litten, RZ | 1 |
Farren, CK; O'Malley, SS | 1 |
2 review(s) available for acamprosate and Depression, Endogenous
Article | Year |
---|---|
[Depression in alcohol addicted patients].
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Comorbidity; Depressive Disorder; Disulfiram; Humans; Naltrexone; Narcotic Antagonists; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Taurine | 2015 |
Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991.
Topics: Acamprosate; Alcohol Withdrawal Delirium; Alcoholism; Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Motivation; Narcotic Antagonists; Psychotropic Drugs; Taurine; Treatment Outcome | 1996 |
1 trial(s) available for acamprosate and Depression, Endogenous
Article | Year |
---|---|
Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety; Australia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Placebos; Secondary Prevention; Taurine; Treatment Outcome | 2006 |
1 other study(ies) available for acamprosate and Depression, Endogenous
Article | Year |
---|---|
Occurrence and management of depression in the context of naltrexone treatment of alcoholism.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Comorbidity; Depressive Disorder; Diagnosis, Dual (Psychiatry); Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Selective Serotonin Reuptake Inhibitors; Taurine | 1999 |